TrialDiabetes, obesity & metabolism2022

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.